Skip to main content

Table 4 Mean costs and EQ-5D-5L outcomes per patient in the adults and older adults cohorts combined

From: Two-year follow-up of a clustered randomised controlled trial of a multicomponent general practice intervention for people at risk of poor health outcomes

 

Control

Intervention

Intervention effectA

 

Baseline

24 months

Baseline

24 months

Coefficient (95% CI)

P-value

Costs (A$)

      

 Hospital

5264 (583)

7554 (1120)

3887 (1041)

5963 (1023)

–214 (–4743 to 4316)

0.926

 Specialist services

3203 (119)

6193 (123)

3378 (57)

6558 (141)

189 (–115 to 492)

0.222

 Pharmaceuticals

2273 (119)

5211 (237)

2272 (387)

5305 (639)

95 (–1334 to 1524)

0.896

 Intervention

0

0

0

1,026

1026 (1026 to 1026)

 < 0.001

 Total costs

10,792 (360)

18,007 (763)

9094 (1362)

17,546 (1524)

1237 (–4249 to 6722)

0.659

Outcomea

      

 EQ-5D-5L

0.607 (0.015)

0.584 (0.015)

0.635 (0.014)

0.620 (0.014)

  

 QALYs gained

 

1.150 (0.038)

 

1.218 (0.028)

0.068 (–0.014 to 0.150)

0.104

  1. Data are mean (standard error [SE]) costs in Australian dollars (A$)
  2. AThe intervention effect is calculated from a multilevel linear regression model. Quality-adjusted life years (QALYs) were calculated from responses on the EuroQoL 5 dimensions, 5 levels (EQ-5D-5L) and questionnaire were adjusted for baseline differences. Baseline, the 12-month period prior to the intervention; 24 months, the 2-year period beginning from the start of the intervention
  3. aIn the base case, an assumption was made that 12 month EQ5D-5L scores were sustained at 24 months. In the QALY calculation, EQ5S-5L values at 24 months were adjusted for the number of decedents (who were assigned values of 0). QALYs were also discounted at 5%
Back to article page

BMC Health Services Research

ISSN: 1472-6963

Contact us